Millie Ray, PhD
InvestorPartner at The Column Group
About
Millie Ray is an MIT-trained PhD who rose from Associate to Partner since 2017 and leverages hands-on experience at Foghorn Therapeutics to found and incubate early-stage drug discovery biology companies.
Invests in
BiotechHealthtech
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
Hui Tian
Partner at The Column Group
Hui Tian, PhD
Partner at The Column Group
James Evangelista
Partner and CFO at The Column Group
JeenJoo Kang
Venture Partner at The Column Group
Frequently asked questions
- Who is Millie Ray, PhD?
- Millie Ray is an MIT-trained PhD who rose from Associate to Partner since 2017 and leverages hands-on experience at Foghorn Therapeutics to found and incubate early-stage drug discovery biology companies.
- Where does Millie Ray, PhD work?
- Millie Ray, PhD is Partner at The Column Group.
- What does Millie Ray, PhD invest in?
- Millie Ray, PhD invests in Biotech, Healthtech.